Last Updated: September 28, 2026

Details for New Drug Application (NDA): 020506

✉ Email this page to a colleague

NDA 020506 describes TIAMATE, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the TIAMATE profile page.

The generic ingredient in TIAMATE is diltiazem malate. There is one drug master file entry for this compound. Additional details are available on the diltiazem malate profile page.

Summary for 020506

Tradename:	TIAMATE
Applicant:	Merck
Ingredient:	diltiazem malate
Patents:	0

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET, EXTENDED RELEASE;ORAL			Strength	EQ 120MG HYDROCHLORIDE
Approval Date:	Oct 4, 1996	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET, EXTENDED RELEASE;ORAL			Strength	EQ 180MG HYDROCHLORIDE
Approval Date:	Oct 4, 1996	TE:		RLD:	No

Profile for product number 003

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET, EXTENDED RELEASE;ORAL			Strength	EQ 240MG HYDROCHLORIDE
Approval Date:	Oct 4, 1996	TE:		RLD:	No

Expired US Patents for NDA 020506

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Merck	TIAMATE	diltiazem malate	TABLET, EXTENDED RELEASE;ORAL	020506-003	Oct 4, 1996	⤷ Start Trial	⤷ Start Trial
Merck	TIAMATE	diltiazem malate	TABLET, EXTENDED RELEASE;ORAL	020506-001	Oct 4, 1996	⤷ Start Trial	⤷ Start Trial
Merck	TIAMATE	diltiazem malate	TABLET, EXTENDED RELEASE;ORAL	020506-002	Oct 4, 1996	⤷ Start Trial	⤷ Start Trial
Merck	TIAMATE	diltiazem malate	TABLET, EXTENDED RELEASE;ORAL	020506-002	Oct 4, 1996	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.